Porcilis® Lawsonia ID lyophilisate and solvent for emulsion for injection for pigs
Vaccine
Product Description
This product page provides information relating to Porcilis Lawsonia ID, for intradermal use. For intramuscular administration please see the Porcilis Lawsonia product page.
Presentation
Lyophilisate: white/nearly white pellet/powder.
Solvent: homogenous white to nearly white emulsion after shaking.
Active ingredients
Each dose of 0.2 ml reconstituted vaccine contains:
Inactivated Lawsonia intracellularis strain SPAH-08 ≥ 5323 U1
1 Antigenic mass units as determined in the in vitro potency test (ELISA).
Target species
Pigs.
Indications for use
For the active immunisation of pigs from 3 weeks of age to reduce diarrhoea, loss of daily weight gain, intestinal lesions, bacterial shedding and mortality caused by Lawsonia intracellularis infection.
Onset of immunity: 4 weeks after vaccination
Duration of immunity: 21 weeks after vaccination
Withdrawal period
Meat: zero days
Amounts to be administered and administration route
A single dose of 0.2 ml of reconstituted vaccine in pigs starting at 3 weeks of age
Reconstitute the lyophilisate in the solvent or in Porcilis PCV ID as follows:
| Lyophilisate | Solvent for Porcilis Lawsonia ID or Porcilis PCV ID |
|---|---|
| 50 doses | 10 ml |
| 100 doses | 20 ml |
Packaging
Lyophilisate:
Hydrolytic glass Type I vial of 50 doses or 100 doses closed with halogenobutyl rubber stoppers and sealed with aluminium caps.
Solvent:
Hydrolytic glass Type I vial of 10 ml closed with nitryl rubber stoppers and sealed with aluminium caps.
PET (polyethylene terephthalate) vials of 20 ml closed with nitryl rubber stoppers and sealed with aluminium caps.
Presentations:
Cardboard box with 1 x 50 doses of vaccine and cardboard box with 1 x 10 ml solvent
Cardboard box with 1 x 100 doses of vaccine and cardboard box with 1 x 20 ml solvent
Legal category
POM-V
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: May 2025
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
